In vivo near-infrared spectroscopy and magnetic resonance imaging monitoring of tumor response to combretastatin A-4-phosphate correlated with therapeutic outcome.
about
Dynamic bioluminescence and fluorescence imaging of the effects of the antivascular agent Combretastatin-A4P (CA4P) on brain tumor xenografts.Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and (19)F MRI.In vivo bioluminescence imaging of tumor hypoxia dynamics of breast cancer brain metastasis in a mouse model.Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models.Acute Temporal Changes of MRI-Tracked Tumor Vascular Parameters after Combined Anti-angiogenic and Radiation Treatments in a Rat Glioma Model: Identifying Signatures of Synergism.Dynamic contrast enhanced fluorescent molecular imaging of vascular disruption induced by combretastatin-A4P in tumor xenografts.Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas.The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells.Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat Cancer.Combination therapy of radiofrequency ablation and bevacizumab monitored with power Doppler ultrasound in a murine model of hepatocellular carcinoma
P2860
Q35322855-06987DDF-85D8-49DA-9C25-C4FD3E7AFC01Q35402062-8C980894-54FE-41DE-A158-11D8AE322D7BQ35581759-0EE3F83E-0D86-4286-A7C8-76E5A97339DFQ38056889-A94B1871-ED1F-458B-AE43-8A4B28AE489BQ38724990-6272AEDA-9461-47EE-8CED-1B657D83AAC8Q38976012-1942C29D-0FA3-48F9-9671-D748AFAC9A95Q48444978-4792B0F0-3470-411E-A744-4E16015068F4Q49302678-39ABAABF-C7E7-434A-A4DD-8975DE889E95Q51795514-78DE6AB2-DCC6-464D-B745-3145B19CA107Q57317511-963D6DD5-E2B4-43DC-8D69-C31DC457D07D
P2860
In vivo near-infrared spectroscopy and magnetic resonance imaging monitoring of tumor response to combretastatin A-4-phosphate correlated with therapeutic outcome.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
In vivo near-infrared spectros ...... ated with therapeutic outcome.
@ast
In vivo near-infrared spectros ...... ated with therapeutic outcome.
@en
type
label
In vivo near-infrared spectros ...... ated with therapeutic outcome.
@ast
In vivo near-infrared spectros ...... ated with therapeutic outcome.
@en
prefLabel
In vivo near-infrared spectros ...... ated with therapeutic outcome.
@ast
In vivo near-infrared spectros ...... ated with therapeutic outcome.
@en
P2093
P2860
P1476
In vivo near-infrared spectros ...... ated with therapeutic outcome.
@en
P2093
Cheng-Hui Chang
Dawen Zhao
Ralph P Mason
P2860
P304
P356
10.1016/J.IJROBP.2010.12.028
P407
P577
2011-02-23T00:00:00Z